Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.026 | 0.3494 | 0.3494 |
Loa Loa (eye worm) | hypothetical protein | 0.0641 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0085 | 0.0085 |
Onchocerca volvulus | 0.0641 | 1 | 0.5 | |
Schistosoma mansoni | sodium-bile acid cotransporter related | 0.0641 | 1 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0085 | 0.0085 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0085 | 0.0085 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.0641 | 1 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.0641 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0085 | 0.0085 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.0641 | 1 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.0641 | 1 | 1 |
Echinococcus multilocularis | sodium bile acid cotransporter | 0.0641 | 1 | 1 |
Echinococcus granulosus | sodium bile acid cotransporter | 0.0641 | 1 | 1 |
Schistosoma mansoni | sodium-bile acid cotransporter | 0.0381 | 0.5563 | 0.5563 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 44.6684 uM | PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.